-
Mon20Jul2026Fri24Jul2026
-
Thu06Aug2026Sat08Aug2026
-
Wed02Sep2026Fri04Sep2026
-
Tue29Sep2026Fri02Oct2026Dubai, United Arab Emirates
-
Wed30Sep2026Sun04Oct2026
-
Wed30Sep2026Sun04Oct2026
-
Sun11Oct2026Thu15Oct2026
-
Mon12Oct2026Fri16Oct2026
Latest News
Stereotaxis completes acquisition of Robocath
Stereotaxis has announced that it has completed its previously announced acquisition of Robocath—an innovator of robotic technologies for interventional cardiology and neurointerventions.
As per a press...
Features
Why mechanical angioplasty deserves a place in the vasospasm treatment algorithm
As part of a PhD programme supervised by Boris Lubicz, Adrien Guenego (both Brussels, Belgium) recently conducted the first prospective randomised trial directly evaluating...
Who funds stroke trials in Europe—and why this matters more than...
Following the release of new findings from a survey conducted by the European Stroke Organisation Trials Alliance (ESOTA) on how clinical trials in stroke...
Videos
"We've had changes in our EVAR devices, we've had changes in our CLTI , lower extremity, PAD intervention devices, so it only makes sense that we're going to have changes in our carotid stenting devices as well."...
